这是一篇来自已证抗体库的有关
人类 PDCD1LG2的综述，是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PDCD1LG2 抗体。
PDCD1LG2 同义词: B7DC; Btdc; CD273; PD-L2; PDCD1L2; PDL2; bA574F11.2
BioLegend
| 小鼠 单克隆（24F.10C12） | | BioLegend PDCD1LG2抗体（BioLegend, 329605)被用于被用于流式细胞仪在人类样本上 (图 s3). Stem Cell Reports (2020) ncbi |
| 小鼠 单克隆（MIH18） | | BioLegend PDCD1LG2抗体（Biolegend, 345505)被用于被用于流式细胞仪在人类样本上 (图 3b). Cell Rep (2019) ncbi |
| 小鼠 单克隆（24F.10C12） | | BioLegend PDCD1LG2抗体（Biolegend, 24F.10C12)被用于被用于流式细胞仪在人类样本上浓度为1:300 (图 2c). JCI Insight (2019) ncbi |
| 小鼠 单克隆（24F.10C12） | | BioLegend PDCD1LG2抗体（BioLegend, 24F.10C12)被用于被用于流式细胞仪在人类样本上 (图 2d). Leukemia (2019) ncbi |
| 小鼠 单克隆（MIH18） | | BioLegend PDCD1LG2抗体（BioLegend, MIH18)被用于被用于流式细胞仪在人类样本上 (图 1c). Front Immunol (2018) ncbi |
| 小鼠 单克隆（MIH18） | | BioLegend PDCD1LG2抗体（BioLegend, MIH18)被用于被用于流式细胞仪在人类样本上 (表 3). Am J Pathol (2017) ncbi |
| 小鼠 单克隆（MIH18） | | BioLegend PDCD1LG2抗体（BioLegend, MIH18)被用于. Clin Cancer Res (2014) ncbi |
安迪生物R&D
| 小鼠 单克隆（176611） | - 免疫组化-石蜡切片; 人类; 1:1000; 图 1a
| 安迪生物R&D PDCD1LG2抗体（R&D, MAB1224-100)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 1a). J Immunother Cancer (2019) ncbi |
| 小鼠 单克隆（176611） | | 安迪生物R&D PDCD1LG2抗体（R&D, MAB1224)被用于被用于免疫组化在人类样本上. Cell (2019) ncbi |
| domestic goat 多克隆 | - 免疫组化-石蜡切片; 人类; 1:500; 图 2
| 安迪生物R&D PDCD1LG2抗体（R&D systems, AF1224)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 2). Breast Cancer Res (2016) ncbi |
赛默飞世尔
| domestic rabbit 多克隆 | | 赛默飞世尔 PDCD1LG2抗体（Thermo Fisher, PA5-20344)被用于被用于免疫印迹在大鼠样本上 (图 2a). J Neuroinflammation (2017) ncbi |
| 小鼠 单克隆（MIH18） | | 赛默飞世尔 PDCD1LG2抗体（eBioscience, MIH18)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:50 (图 2). F1000Res (2015) ncbi |
| 小鼠 单克隆（MIH18） | | 赛默飞世尔 PDCD1LG2抗体（eBioscience, MIH18)被用于被用于流式细胞仪在人类样本上. PLoS Negl Trop Dis (2014) ncbi |
| 小鼠 单克隆（MIH18） | | 赛默飞世尔 PDCD1LG2抗体（eBioscience, MIH18)被用于被用于免疫印迹在小鼠样本上. Arthritis Rheum (2010) ncbi |
圣克鲁斯生物技术
| 小鼠 单克隆（XX19） | | 圣克鲁斯生物技术 PDCD1LG2抗体（SantaCruz, sc-80285)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Cancer Sci (2016) ncbi |
碧迪BD
| 小鼠 单克隆（MIH18） | | 碧迪BD PDCD1LG2抗体（BD, MIH18)被用于被用于流式细胞仪在人类样本上 (图 s5a). JCI Insight (2018) ncbi |
| 小鼠 单克隆（MIH18） | | 碧迪BD PDCD1LG2抗体（BD, 558066)被用于被用于流式细胞仪在人类样本上 (图 st1). Exp Cell Res (2016) ncbi |
| 小鼠 单克隆（MIH18） | | 碧迪BD PDCD1LG2抗体（BD, 563842)被用于被用于流式细胞仪在人类样本上 (图 3b,e). PLoS Pathog (2015) ncbi |
| 小鼠 单克隆（MIH18） | | 碧迪BD PDCD1LG2抗体（BD Pharmingen, clone MIH18)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi |
Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A,
et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59
pubmed 出版商 Zhang Y, Xu J, Hua J, Liu J, Liang C, Meng Q,
et al. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma. J Immunother Cancer. 2019;7:233
pubmed 出版商 Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C,
et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7
pubmed 出版商 Lee J, Park S, Park H, Kim S, Lee J, Lee J,
et al. Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma. Cell. 2019;177:1842-1857.e21
pubmed 出版商 Geng Y, Liu X, Liang J, Habiel D, Kulur V, Coelho A,
et al. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI Insight. 2019;4:
pubmed 出版商 Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y,
et al. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia. 2019;:
pubmed 出版商 Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603
pubmed 出版商 Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F,
et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3:
pubmed 出版商 Wu J, Sun L, Li H, Shen H, Zhai W, Yu Z,
et al. Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory phenotype. J Neuroinflammation. 2017;14:36
pubmed 出版商 Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317
pubmed 出版商 Ogiya R, Niikura N, Kumaki N, Bianchini G, Kitano S, Iwamoto T,
et al. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Cancer Sci. 2016;107:1730-1735
pubmed 出版商 Duchnowska R, Pęksa R, Radecka B, Mandat T, Trojanowski T, Jarosz B,
et al. Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis. Breast Cancer Res. 2016;18:43
pubmed 出版商 Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9
pubmed 出版商 Gulati N, Suárez Fariñas M, Correa Da Rosa J, Krueger J. Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions. F1000Res. 2015;4:149
pubmed 出版商 McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C,
et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914
pubmed 出版商 Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B,
et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620
pubmed 出版商 O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A,
et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206
pubmed 出版商 Taube J, Klein A, Brahmer J, Xu H, Pan X, Kim J,
et al. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res. 2014;20:5064-74
pubmed 出版商 Raptopoulou A, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I, Tzardi M,
et al. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum. 2010;62:1870-80
pubmed 出版商
